| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0008 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |